Skip to main content

Elms Steve

In the past year, 1 open-market purchase filing worth $217.4K and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$217.4K
1 filing
Sold
–
0 filings
Net
+$217.4K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Elms Steve as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ADMA Adma Biologics, Inc.

Director5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 9, 2026 (view filing)Mar 5-64 daysElms SteveDirectorPPurchase+14.0K$15.53+$217.4K+0.7%2.05M after2 lots
Jun 16, 2025 (view filing)Jun 124 daysElms SteveDirectorSSale−92.9K$21.69−$2.02M−4.4%2.03M after
Jun 16, 2025 (view filing)Jun 13-163 daysElms SteveDirectorSSale−332.7K$20.48−$6.81M−79.2%87.3K after2 lots
Mar 19, 2024 (view filing)Mar 18-191 dayElms SteveDirectorSSale−461.7K$6.07−$2.80M−17.9%2.12M after2 lots
Mar 15, 2024 (view filing)Mar 13-152 daysElms SteveDirectorSSale−1.04M$6.11−$6.34M−28.7%2.58M after3 lots

MRKR Marker Therapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 26, 2024 (view filing)Dec 233 daysElms SteveDirectorPPurchase+11.1K$3.20+$35.5K+3.5%325.4K after

Elevation Oncology, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 1, 2021 (view filing)6:29 PM ETJun 292 daysElms Steve and 4 othersDirector, Other: Managing MemberPPurchase+187.5K$16.00+$3.00M+7.1%2.83M after